Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Provision for income tax	$ 15	$ 15
Effective tax rate	(0.40%)	(0.20%)

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.